Roche (RHHBY) Actemra Gets CHMP Recommendation for COVID-19 Posted byZacks Equity Research December 7, 2021 Leave a comment on Roche (RHHBY) Actemra Gets CHMP Recommendation for COVID-19 The CHMP recommends EU approval for Roche’s (RHHBY) Actemra to treat patients with severe COVID-19.